Literature DB >> 1506685

Molecular cloning of the NK1.1 antigen, a member of the NKR-P1 family of natural killer cell activation molecules.

J C Ryan1, J Turck, E C Niemi, W M Yokoyama, W E Seaman.   

Abstract

In mice, the NK1.1 alloantigen is expressed on all NK cells and it initiates transmembrane signals that activate cytotoxicity. NK1.1 has been mapped to a chromosomal region that encodes two families of receptor-like molecules, the NKR-P1 family and the Ly-49 family. Both of these gene families encode type II integral membrane proteins whose extracellular domains are homologous with known C-type lectins. We have isolated and expressed a member of the NKR-P1 gene family (mNKR-P1.9) and have demonstrated both by immunofluorescence and by immunoprecipitation that this cDNA encodes NK1.1. These findings, which demonstrate the receptor-like structure of NK1.1, will facilitate studies regarding the role of NK1.1 in natural killing and regarding the identification of possible NK1.1 ligands.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1506685

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

1.  Characterization of a surface membrane molecule expressed by natural killer cells in most inbred mouse strains: monoclonal antibody C9.1 identifies an allelic form of the 2B4 antigen.

Authors:  K Kubota; H Katoh; K Muguruma; K Koyama
Journal:  Immunology       Date:  1999-03       Impact factor: 7.397

2.  On the cell biology of pit cells, the liver-specific NK cells.

Authors:  Dian-Zhong Luo; David Vermijlen; Bulent Ahishali; Vasilis Triantis; Georgia Plakoutsi; Filip Braet; Karin Vanderkerken; Eddie Wisse
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

3.  In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection.

Authors:  Takafumi Yagisawa; Toshiaki Tanaka; Satoshi Miyairi; Kazunari Tanabe; Nina Dvorina; Wayne M Yokoyama; Anna Valujskikh; William M Baldwin; Robert L Fairchild
Journal:  Kidney Int       Date:  2018-11-29       Impact factor: 10.612

Review 4.  NKR-P1 biology: from prototype to missing self.

Authors:  Aruz Mesci; Belma Ljutic; Andrew P Makrigiannis; James R Carlyle
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 5.  Investigation of NK cell function and their modulation in different malignancies.

Authors:  Gordana Konjevic; Vladimir Jurisic; Viktor Jovic; Ana Vuletic; Katarina Mirjacic Martinovic; Sandra Radenkovic; Ivan Spuzic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

6.  Analysis of the mouse 129-strain Nkrp1-Clr gene cluster reveals conservation of genomic organization and functional receptor-ligand interactions despite significant allelic polymorphism.

Authors:  Peter Chen; Simon Bélanger; Oscar A Aguilar; Qiang Zhang; Aaron St-Laurent; M Munir Ahmad Rahim; Andrew P Makrigiannis; James R Carlyle
Journal:  Immunogenetics       Date:  2011-06-11       Impact factor: 2.846

7.  The BALB.B6-Cmv1r mouse: a strain congenic for Cmv1 and the NK gene complex.

Authors:  A A Scalzo; P A Lyons; N A Fitzgerald; C A Forbes; G R Shellam
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

8.  Chromosome mapping of Rmp-4, a gonad-dependent gene encoding host resistance to mousepox.

Authors:  D G Brownstein; L Gras
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

Review 9.  Natural killer cell immune responses.

Authors:  Wayne M Yokoyama
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

10.  Chemo-immunotherapy mediates durable cure of orthotopic KrasG12D/p53-/- pancreatic ductal adenocarcinoma.

Authors:  Vanaja Konduri; Dali Li; Matthew M Halpert; Dan Liang; Zhengdong Liang; Yunyu Chen; William E Fisher; Silke Paust; Jonathan M Levitt; Qizhi Cathy Yao; William K Decker
Journal:  Oncoimmunology       Date:  2016-07-22       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.